Results 101 to 110 of about 213,836 (266)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Monoclonal antibodies to the cells of a regenerating limb [PDF]

, 1985
Monoclonal antibodies were raised against differentiated cells, and blastemal cells from regenerating limbs of adult newts (Notophthalmus viridescens) and screened for specific staining by immunocytochemistry.
Brockes, Jeremy P., Kintner, Chris R.
core  

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Clinical outcome of Two Minute Walk Test after return to run program in IDEO users: a retrospective study

Frontiers in Rehabilitation Sciences
ObjectiveTo investigate clinical improvement in persons with severe musculoskeletal injuries following a 4-week high intensity sports-based return to run rehabilitation therapy program (RTR) combined with use of an Intrepid Dynamic Exoskeletal Orthosis ...
Michelle D. Lockwood, Michelle D. Lockwood, Michelle D. Lockwood, Christopher F. Hovorka, Christopher F. Hovorka, Molly E. Baumann, Molly E. Baumann, Molly E. Baumann, W. Lee Childers, W. Lee Childers, W. Lee Childers   +10 more
doaj   +1 more source

Cutting edge strategies for diabetic wound care: Nanotechnology, bioengineering, and beyond

BMEMat, EarlyView.
Graphical abstract illustrates the challenges in diabetic wound healing, covering pathophysiology, formulation hurdles, and emerging therapeutic strategies. It highlights the role of hyperglycemia, formulation complexities, and advanced technologies like bioprinting and AI in improving diabetic wound management. Abstract Diabetic wounds affect millions
Usama Ahmad, Wan Nurhidayah Wan Hanaffi, Anas Islam, Aimen Salman, Mohd Muazzam Khan, Faiyaz Shakeel, Qiang Cai, Xiaojun Cai, Quazi T. H. Shubhra   +8 more
wiley   +1 more source

Marine silicon for biomedical sustainability

BMEMat, EarlyView.
Schematic illustrating marine silicon for biomedical engineering. Abstract Despite momentous divergence from oceanic origin, human beings and marine organisms exhibit elemental homology through silicon utilization. Notably, silicon serves as a critical constituent in multiple biomedical processes.
Yahui Han, Zhibo Yang, Wei Xia, Chengtie Wu   +3 more
wiley   +1 more source

Variability in UK Body Donation Information: A Comparison of Bequeathal Information and Consent Forms With Recommendations for Standardization

Clinical Anatomy, EarlyView.
ABSTRACT The use of human donor bodies for anatomical examination in the United Kingdom is regulated by the Human Tissue Authority (England, Wales, and Northern Ireland) and His Majesty's Inspector of Anatomy for Scotland. This study aimed to assess the variability of information provided to body donors and the associated consent forms across UK ...
Janet A. C. Philp, Kat A. Sanders
wiley   +1 more source

Atherectomy With Multimodal Embolic Protection for Severely Calcified Femoropopliteal Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe calcification in femoropopliteal lesions remains a clinical challenge to achieve both the technical and long‐term success in endovascular therapy. Although atherectomy is an effective treatment for calcified lesions, it is associated with the risk of distal embolization, even with the use of embolic protection devices (EPDs), and ...
Daichi Yoshii, Osamu Iida, Taku Toyoshima, Yoshiteru Okina   +3 more
wiley   +1 more source

Postoperative care in finger replantation. Our case-load and review of the literature [PDF]

, 2015
OBJECTIVE: Technical success of a finger replantation depends on several factors such as surgical procedure, type of injury, number of segments amputated, amputation level and individual patient factors.
Chen, Hc, Cigna, Emanuele, LO TORTO, Federico, Maruccia, Michele, Ribuffo, Diego, Ruggieri, M, Zaccheddu, F   +6 more
core